1
|
Hastings A, Cullinane P, Wrigley S, Revesz T, Morris HR, Dickson JC, Jaunmuktane Z, Warner TT, De Pablo-Fernández E. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism. Neurology 2024; 102:e209453. [PMID: 38759132 DOI: 10.1212/wnl.0000000000209453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/19/2024] Open
Abstract
BACKGROUND AND OBJECTIVES Degeneration of the presynaptic nigrostriatal dopaminergic system is one of the main biological features of Parkinson disease (PD), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD), which can be measured using single-photon emission CT imaging for diagnostic purposes. Despite its widespread use in clinical practice and research, the diagnostic properties of presynaptic nigrostriatal dopaminergic (DAT) imaging in parkinsonism have never been evaluated against the diagnostic gold standard of neuropathology. The aim of this study was to evaluate the diagnostic parameters of DAT imaging compared with pathologic diagnosis in patients with parkinsonism. METHODS Retrospective cohort study of patients with DAT imaging for the investigation of a clinically uncertain parkinsonism with brain donation between 2010 and 2021 to the Queen Square Brain Bank (London). Patients with DAT imaging for investigation of pure ataxia or dementia syndromes without parkinsonism were excluded. Those with a pathologic diagnosis of PD, MSA, PSP, or CBD were considered presynaptic dopaminergic parkinsonism, and other pathologies were considered postsynaptic for the analysis. DAT imaging was performed in routine clinical practice and visually classified by hospital nuclear medicine specialists as normal or abnormal. The results were correlated with neuropathologic diagnosis to calculate diagnostic accuracy parameters for the diagnosis of presynaptic dopaminergic parkinsonism. RESULTS All of 47 patients with PD, 41 of 42 with MSA, 68 of 73 with PSP, and 6 of 10 with CBD (sensitivity 100%, 97.6%, 93.2%, and 60%, respectively) had abnormal presynaptic dopaminergic imaging. Eight of 17 patients with presumed postsynaptic parkinsonism had abnormal scans (specificity 52.9%). DISCUSSION DAT imaging has very high sensitivity and negative predictive value for the diagnosis of presynaptic dopaminergic parkinsonism, particularly for PD. However, patients with CBD, and to a lesser extent PSP (of various phenotypes) and MSA (with predominant ataxia), can show normal DAT imaging. A range of other neurodegenerative disorders may have abnormal DAT scans with low specificity in the differential diagnosis of parkinsonism. DAT imaging is a useful diagnostic tool in the differential diagnosis of parkinsonism, although clinicians should be aware of its diagnostic properties and limitations. CLASSIFICATION OF EVIDENCE This study provides Class II evidence that DAT imaging does not accurately distinguish between presynaptic dopaminergic parkinsonism and non-presynaptic dopaminergic parkinsonism.
Collapse
Affiliation(s)
- Alexandra Hastings
- From the Queen Square Brain Bank for Neurological Disorders (A.H., P.C., S.W., T.R., Z.J., T.T.W., E.D.P.-F.) and Department of Clinical and Movement Neurosciences (H.R.M.), University College London Queen Square Institute of Neurology; and Institute of Nuclear Medicine (J.C.D.), University College London Hospitals NHS Trust, UK
| | - Patrick Cullinane
- From the Queen Square Brain Bank for Neurological Disorders (A.H., P.C., S.W., T.R., Z.J., T.T.W., E.D.P.-F.) and Department of Clinical and Movement Neurosciences (H.R.M.), University College London Queen Square Institute of Neurology; and Institute of Nuclear Medicine (J.C.D.), University College London Hospitals NHS Trust, UK
| | - Sarah Wrigley
- From the Queen Square Brain Bank for Neurological Disorders (A.H., P.C., S.W., T.R., Z.J., T.T.W., E.D.P.-F.) and Department of Clinical and Movement Neurosciences (H.R.M.), University College London Queen Square Institute of Neurology; and Institute of Nuclear Medicine (J.C.D.), University College London Hospitals NHS Trust, UK
| | - Tamas Revesz
- From the Queen Square Brain Bank for Neurological Disorders (A.H., P.C., S.W., T.R., Z.J., T.T.W., E.D.P.-F.) and Department of Clinical and Movement Neurosciences (H.R.M.), University College London Queen Square Institute of Neurology; and Institute of Nuclear Medicine (J.C.D.), University College London Hospitals NHS Trust, UK
| | - Huw R Morris
- From the Queen Square Brain Bank for Neurological Disorders (A.H., P.C., S.W., T.R., Z.J., T.T.W., E.D.P.-F.) and Department of Clinical and Movement Neurosciences (H.R.M.), University College London Queen Square Institute of Neurology; and Institute of Nuclear Medicine (J.C.D.), University College London Hospitals NHS Trust, UK
| | - John C Dickson
- From the Queen Square Brain Bank for Neurological Disorders (A.H., P.C., S.W., T.R., Z.J., T.T.W., E.D.P.-F.) and Department of Clinical and Movement Neurosciences (H.R.M.), University College London Queen Square Institute of Neurology; and Institute of Nuclear Medicine (J.C.D.), University College London Hospitals NHS Trust, UK
| | - Zane Jaunmuktane
- From the Queen Square Brain Bank for Neurological Disorders (A.H., P.C., S.W., T.R., Z.J., T.T.W., E.D.P.-F.) and Department of Clinical and Movement Neurosciences (H.R.M.), University College London Queen Square Institute of Neurology; and Institute of Nuclear Medicine (J.C.D.), University College London Hospitals NHS Trust, UK
| | - Thomas T Warner
- From the Queen Square Brain Bank for Neurological Disorders (A.H., P.C., S.W., T.R., Z.J., T.T.W., E.D.P.-F.) and Department of Clinical and Movement Neurosciences (H.R.M.), University College London Queen Square Institute of Neurology; and Institute of Nuclear Medicine (J.C.D.), University College London Hospitals NHS Trust, UK
| | - Eduardo De Pablo-Fernández
- From the Queen Square Brain Bank for Neurological Disorders (A.H., P.C., S.W., T.R., Z.J., T.T.W., E.D.P.-F.) and Department of Clinical and Movement Neurosciences (H.R.M.), University College London Queen Square Institute of Neurology; and Institute of Nuclear Medicine (J.C.D.), University College London Hospitals NHS Trust, UK
| |
Collapse
|
2
|
Alexandre-Santos L, Trevisan AC, Pitella FA, Tumas V, Silvah JH, Kato M, de Moraes ER, Wichert-Ana L. Assessment of different regions of interest-based methods for [99mTc]Tc DAT-SPECT quantification using an anthropomorphic striatal phantom. EJNMMI Phys 2022; 9:91. [PMID: 36577862 PMCID: PMC9797635 DOI: 10.1186/s40658-022-00519-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Accepted: 12/06/2022] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND AND AIMS Molecular imaging of the dopamine transporters (DAT) provides valuable information about neurodegenerative diseases, such as Parkinson's. This study assessed the accuracy and precision of DAT-SPECT quantification methods. METHODS Twenty-three DAT-SPECT images of a striatal phantom were acquired. The specific (caudate and putamen) and the non-specific (background activity) chambers were filled with [99mTc]Tc. Different specific-to-non-specific activity ratios (10, 9, 8, 7, 6, 5, 4, 3 and 2 to 1) and the specific binding ratio (SBR) were calculated. Five methods using ROIs were assessed: (a) Manual ROIs on SPECT images; (b) TwoBox and (c) ThreeBox methods and Volume of Interest (VOI) using structural images; (d) MRI and (e) CT. Accuracy was evaluated by the concordance correlation coefficient (CCC) and precision by Pearson's coefficient and linear regression. RESULTS The SBR quantified in the specific and striatal chambers resulted in a CCC increase with a decrease in the nominal values. For lower SBR, MRI and CT showed higher CCCs when caudate ([Formula: see text] = 0.89 e [Formula: see text] = 0.84) and putamen ([Formula: see text] = 0.86 e [Formula: see text] = 0.82) were evaluated. For striatal assessments, the TwoBox method was the most accurate ([Formula: see text] = 0.95). High Pearson's coefficients were found in the correlations between all methods. CONCLUSIONS All five methods showed high precision even when applied to images with different activities. MRI and CT were the most accurate for assessing the caudate or putamen. To assess the striatal chamber and in the absence of structural information, the TwoBox method is advisable.
Collapse
Affiliation(s)
- Leonardo Alexandre-Santos
- grid.11899.380000 0004 1937 0722Nuclear Medicine and PET/CT Section, Department of Medical Imaging, Hematology, and Clinical Oncology, University of São Paulo (USP), Ribeirão Preto, Brazil ,grid.11899.380000 0004 1937 0722Interunits Bioengineering Postgraduation Program, São Carlos School of Engineering, University of São Paulo (USP), São Carlos, Brazil
| | - Ana Carolina Trevisan
- grid.11899.380000 0004 1937 0722Nuclear Medicine and PET/CT Section, Department of Medical Imaging, Hematology, and Clinical Oncology, University of São Paulo (USP), Ribeirão Preto, Brazil ,grid.11899.380000 0004 1937 0722Interunits Bioengineering Postgraduation Program, São Carlos School of Engineering, University of São Paulo (USP), São Carlos, Brazil
| | - Felipe Arriva Pitella
- grid.11899.380000 0004 1937 0722Nuclear Medicine and PET/CT Section, Department of Medical Imaging, Hematology, and Clinical Oncology, University of São Paulo (USP), Ribeirão Preto, Brazil
| | - Vitor Tumas
- grid.11899.380000 0004 1937 0722Interunits Bioengineering Postgraduation Program, São Carlos School of Engineering, University of São Paulo (USP), Ribeirão Preto, Brazil
| | - Jose Henrique Silvah
- grid.11899.380000 0004 1937 0722Nuclear Medicine and PET/CT Section, Department of Medical Imaging, Hematology, and Clinical Oncology, University of São Paulo (USP), Ribeirão Preto, Brazil
| | - Mery Kato
- grid.11899.380000 0004 1937 0722Nuclear Medicine and PET/CT Section, Department of Medical Imaging, Hematology, and Clinical Oncology, University of São Paulo (USP), Ribeirão Preto, Brazil
| | - Eder Rezende de Moraes
- grid.11899.380000 0004 1937 0722Department of Physics, Faculty of Philosophy, Sciences and Literature of Ribeirão Preto (FFCLRP), University of São Paulo (USP), Ribeirão Preto, Brazil
| | - Lauro Wichert-Ana
- grid.11899.380000 0004 1937 0722Nuclear Medicine and PET/CT Section, Department of Medical Imaging, Hematology, and Clinical Oncology, University of São Paulo (USP), Ribeirão Preto, Brazil ,grid.11899.380000 0004 1937 0722Interunits Bioengineering Postgraduation Program, São Carlos School of Engineering, University of São Paulo (USP), São Carlos, Brazil ,grid.11899.380000 0004 1937 0722The Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), Center of Nuclear Medicine, University of São Paulo (USP), São Paulo, Brazil
| |
Collapse
|
3
|
Huang G, Lin C, Cai Y, Chen T, Hsu S, Lu N, Chen H, Wu Y. Multiclass machine learning classification of functional brain images for Parkinson's disease stage prediction. Stat Anal Data Min 2020. [DOI: 10.1002/sam.11480] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Guan‐Hua Huang
- Institute of Statistics, National Chiao Tung University Hsinchu Taiwan
| | - Chih‐Hsuan Lin
- Institute of Statistics, National Chiao Tung University Hsinchu Taiwan
| | - Yu‐Ren Cai
- Institute of Statistics, National Chiao Tung University Hsinchu Taiwan
| | - Tai‐Been Chen
- Department of Medical Imaging and Radiological SciencesI‐Shou University Kaohsiung Taiwan
| | - Shih‐Yen Hsu
- Department of Information EngineeringI‐Shou University Kaohsiung Taiwan
| | - Nan‐Han Lu
- Department of Medical Imaging and Radiological SciencesI‐Shou University Kaohsiung Taiwan
- Department of PharmacyTajen University Pingtung Taiwan
- Department of RadiologyE‐Da Hospital, I‐Shou University Kaohsiung Taiwan
- School of Medicine, College of Medicine, I‐Shou University Kaohsiung Taiwan
| | - Huei‐Yung Chen
- Department of Nuclear MedicineE‐Da Hospital, I‐Shou University Kaohsiung Taiwan
| | - Yi‐Chen Wu
- Department of Nuclear MedicineE‐Da Hospital, I‐Shou University Kaohsiung Taiwan
| |
Collapse
|
4
|
Diagnosis of Parkinson’s Disease at an Early Stage Using Volume Rendering SPECT Image Slices. ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING 2019. [DOI: 10.1007/s13369-019-04152-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
5
|
Navalpotro-Gomez I, Dacosta-Aguayo R, Molinet-Dronda F, Martin-Bastida A, Botas-Peñin A, Jimenez-Urbieta H, Delgado-Alvarado M, Gago B, Quiroga-Varela A, Rodriguez-Oroz MC. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders. Eur J Nucl Med Mol Imaging 2019; 46:2065-2076. [PMID: 31273436 DOI: 10.1007/s00259-019-04396-3] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2019] [Accepted: 06/10/2019] [Indexed: 01/11/2023]
Abstract
PURPOSE Previous studies in patients with Parkinson's disease (PD) and impulse control disorders (ICDs) have produced heterogeneous results regarding striatal dopamine transporter (DaT) binding and activity in the mesocorticolimbic network. Our aim here was to study the relationship between striatal DaT availability and cortical metabolism, as well as motor, behavioural and cognitive features of PD patients with ICD. METHODS In a group of PD patients with ICD (PD-ICD, n = 16) and 16 matched PD patients without ICD (PD-noICD, n = 16), DaT single-photon emission computed tomography (SPECT) imaging (DaTSCAN) was used to study DaT availability in predefined striatal volumes of interest (VOIs): putamen, caudate nucleus and ventral striatum (VS). In addition, the specific association of striatal DaT binding with cortical limbic and associative metabolic activity was evaluated by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in PD-ICD patients and investigated using statistical parametric mapping (SPM8). Finally, associations between DaT availability and motor, behavioural and cognitive features were assessed. RESULTS PD-ICD patients had a significantly lower DaT density in the VS than PD-noICD patients, which was inversely associated with ICD severity. Lower DaT availability in the VS was associated with lower FDG uptake in several cortical areas belonging to the limbic and associative circuits, and in other regions involved in reward and inhibition processes (p < 0.0001 uncorrected; k > 50 voxels). No significant results were observed using a higher conservative threshold (p < 0.05; FDR corrected). PD-ICD patients also displayed impairment in interference and attentional Stroop Task execution, and more anxiety, all associated with reduced DaT availability in the VS and caudate nucleus. CONCLUSIONS ICDs in PD patients are related to reduced DaT binding in the VS, which accounts for dysfunction in a complex cortico-subcortical network that involves areas of the mesolimbic and mesocortical systems, being associated with reward evaluation, salience attribution and inhibitory control processes.
Collapse
Affiliation(s)
- I Navalpotro-Gomez
- Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastian, Spain.,Network Center for Biomedical Research in Neurodegenerative Diseases, CIBERNED, Madrid, Spain
| | - R Dacosta-Aguayo
- Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastian, Spain.,Network Center for Biomedical Research in Neurodegenerative Diseases, CIBERNED, Madrid, Spain
| | - F Molinet-Dronda
- MicroPET Research Unit, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain
| | - A Martin-Bastida
- Department of Neurology, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain
| | - A Botas-Peñin
- Department of Biomedical Engineering, Tecnun, Universidad de Navarra, Pamplona, Spain
| | - H Jimenez-Urbieta
- Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastian, Spain.,Network Center for Biomedical Research in Neurodegenerative Diseases, CIBERNED, Madrid, Spain
| | - M Delgado-Alvarado
- Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastian, Spain.,Network Center for Biomedical Research in Neurodegenerative Diseases, CIBERNED, Madrid, Spain.,Neurology Department, Sierrallana Hospital, Torrelavega, Spain
| | - B Gago
- Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastian, Spain.,Network Center for Biomedical Research in Neurodegenerative Diseases, CIBERNED, Madrid, Spain
| | - A Quiroga-Varela
- Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastian, Spain.,Network Center for Biomedical Research in Neurodegenerative Diseases, CIBERNED, Madrid, Spain.,Neuroscience Area, Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain
| | - Maria C Rodriguez-Oroz
- Network Center for Biomedical Research in Neurodegenerative Diseases, CIBERNED, Madrid, Spain. .,Department of Neurology, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain. .,Neuroscience Area, Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain. .,Ikerbasque (Basque Foundation of Science), Bilbao, Spain. .,Basque Center on Cognition, Brain and Language (BCBL), San Sebastian, Spain.
| |
Collapse
|
6
|
Abstract
PURPOSE OF REVIEW While establishing the diagnosis of Parkinson disease (PD) can be straightforward, it can be challenging in some patients, even for the experienced neurologist. The misdiagnosis rate ranges from 10% to 20% or greater depending on clinician experience. RECENT FINDINGS Despite promise in the search for a biomarker that can establish the presence of PD and act as a marker of its progression, the diagnosis of PD continues to be based on clinical examination. Core criteria, exclusion criteria, and supportive criteria have been developed to aid the clinician in establishing the diagnosis. Nonmotor symptoms of PD are usually present at the time of diagnosis, may precede motor symptoms, and should be specifically sought during evaluation. Ancillary testing can be appropriate, but its indications and utility must be clearly understood. SUMMARY The diagnosis of PD requires the recognition of the core features of PD and the differentiation of its clinical presentation from other entities with similar and potentially overlapping symptoms. A careful history and examination guided by clinical diagnostic criteria will usually establish the diagnosis of PD or uncover red flags for the possibilities of other diagnoses. Appropriate selection and interpretation of ancillary testing is critical to avoid misdiagnosis and unnecessary tests.
Collapse
|
7
|
Eggers C, Holstein A, Schneider C, Pedrosa DJ, Dietlein M, Kobe C, Timmermann L, Schmidt M, Kahraman D. 123I-FP-CIT SPECT imaging of the dopaminergic state. Nuklearmedizin 2017; 51:244-51. [DOI: 10.3413/nukmed-0449-11-12] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2011] [Accepted: 04/17/2012] [Indexed: 11/20/2022]
Abstract
Summary123I-N-ω-fluoropropyl-2β-carbomethoxy-3β- (4-iodophenyl)nortropan (123I-FP-CIT) single photon emission computed tomography (SPECT) can be evaluated by both visual assessment and quantitative analysis to assess the striatal dopamine state in vivo. The aim of our study was to investigate if visual assessment according to a predefined image grading scale reflects the results of quantitative assessment techniques. Patients, methods: 195 patients with a clinical diagnosis of idiopathic Parkinson's disease (n = 134), atypical parkinsonian syndrome (n = 47) or essential tremor (n = 14) were examined with 123I-FP-CIT SPECT and included in this retrospective study. Results were analysed according to predefined visual patterns of dopaminergic degeneration and graded as normal (grade 5) or abnormal (grade 1–4) independently by three raters. Quantitative two-dimensional (2D) operator-dependent, manual and three-dimensional (3D) operator- independent, automated approaches were used for quantitative analysis of the specific 123I-FP-CIT tracer binding ratio (SBR) for caudate and putamen. Results: Sensitivity, specificity, PPV, NPV and diagnostic accuracy of visual assessment of 123I-FP-CIT SPECT for the diagnosis of a neuro degenerative Parkinson's syndrome were 99%, 86%, 99%, 86% and 98%, respectively. Visual assessment and quantitative analysis agreed well in evaluating the degree of dopaminergic degeneration. Significant differences (p < 0.001) were found between degeneration patterns. Only between the so-called eagle wing degeneration and the normal pattern no significant differences in SBR caudate and putamen were found, neither by the quantitative manual (p = 1.00; p = 0.196) nor by the quantitative automated method (p = 1.0; p = 0.785). Inter-rater agreement for visual assessment was substantial for all possible pairs of the three raters (κ = 0.70 to 0.74). Strong correlations were observed between the quantitative manual and quantitative automated methods for quantification of SBR caudatum (r = 0.920, r2 = 0.846, p < 0.001) and SBR putamen (r = 0.908, r2 = 0.824, p < 0.001). Conclusion: Visual assessment was highly consistent with the results obtained by quantitative analysis and showed a substantial inter-rater agreement between experienced and inexperienced raters. Our findings indicate that visual assessment might be a reliable analysis approach for clinical routine.
Collapse
|
8
|
Nocker M, Seppi K, Boesch S, Donnemiller E, Virgolini I, Wenning GK, Poewe W, Scherfler C. Topography of Dopamine Transporter Availability in the Cerebellar Variant of Multiple System Atrophy. Mov Disord Clin Pract 2016; 4:389-396. [PMID: 30363469 DOI: 10.1002/mdc3.12446] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2016] [Revised: 08/09/2016] [Accepted: 08/16/2016] [Indexed: 11/06/2022] Open
Abstract
Background Voxel-wise comparison of [123I]-2β-carbomethoxy-3beta-(4-iodophenyl)tropane ([123I]β-CIT) radioligand distribution measured by single-photon emission computed tomography (SPECT) revealed distinct patterns of reduced dopamine transporter (DAT) availability in the Parkinson's variant of MSA (MSA-P). The aim of this study was to identify the monoamine transporter distribution pattern in patients with the cerebellar variant of MSA (MSA-C). Additionally, monoamine transporter availability was investigated in a small cohort of patients with sporadic adult-onset ataxia (SAOA). Methods [123I]β-CIT SPECT was performed in patients with MSA-C (n = 12), MSA-P (n = 14), SAOA (n = 5), and controls (n = 15) matched for age. Parametric images of [123I]β-CIT binding potential (BPND) were generated and analyzed by statistical parametric mapping (SPM) and region of interest (ROI) analysis. Results SPM localized significant reductions of [123I]β-CIT BPND in the striatum, midbrain, and pons in MSA-C compared to controls. When compared with MSA-P, the striatal DAT decline was significantly less affected in MSA-C. ROI analysis revealed reductions of striatal and midbrain [123I]β-CIT binding in MSA-C compared to SAOA, whereas no significant difference was apparent between the SAOA and control groups. Conclusions Midbrain and pontine monoaminergic transporter binding was severely impaired in MSA-C, matching the underlying pathological features. Striatal DAT availability was relatively less affected in MSA-C compared to MSA-P, reflecting measureable, but less-profound, degeneration of the nigrostriatal dopaminergic projections. Preliminary results of reduced striatal and midbrain [123I]β-CIT binding in MSA-C, compared to SAOA, suggest that the potential of DAT-SPECT as a surrogate marker in the diagnostic workup of patients with adult-onset cerebellar ataxia should be further investigated.
Collapse
Affiliation(s)
- Michael Nocker
- Department of Neurology Medical University of Innsbruck Innsbruck Austria
| | - Klaus Seppi
- Department of Neurology Medical University of Innsbruck Innsbruck Austria
| | - Sylvia Boesch
- Department of Neurology Medical University of Innsbruck Innsbruck Austria
| | - Eveline Donnemiller
- Department of Nuclear Medicine Medical University of Innsbruck Innsbruck Austria
| | - Irene Virgolini
- Department of Nuclear Medicine Medical University of Innsbruck Innsbruck Austria
| | - Gregor K Wenning
- Department of Neurology Medical University of Innsbruck Innsbruck Austria
| | - Werner Poewe
- Department of Neurology Medical University of Innsbruck Innsbruck Austria
| | | |
Collapse
|
9
|
Mäkinen E, Joutsa J, Johansson J, Mäki M, Seppänen M, Kaasinen V. Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism. J Neural Transm (Vienna) 2016; 123:1309-1318. [DOI: 10.1007/s00702-016-1586-6] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2016] [Accepted: 06/12/2016] [Indexed: 10/21/2022]
|
10
|
Functional volumetric analysis of striatum using F-18 FP-CIT PET in patients with idiopathic Parkinson's disease and normal subjects. Ann Nucl Med 2016; 30:572-8. [PMID: 27283185 DOI: 10.1007/s12149-016-1096-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2016] [Accepted: 06/03/2016] [Indexed: 10/21/2022]
Abstract
OBJECTIVE We applied a simple isocontour volume-of-interest (VOI) method to analyze the whole striatum in an F-18 FP-CIT PET image and to investigate the usefulness of the method in differentiating healthy subjects from idiopathic Parkinson's disease (IPD) patients and the correlation of the value of functional volume parameters with the motor symptoms in patients with IPD. METHODS Forty-three IPD patients and 23 age-matched healthy controls underwent F-18 FP-CIT PET. Using a dedicated workstation, VOIs for the whole striatum were drawn automatically with the gradient delineation method. The SUVmax, SUVmean, functional volume (FV), striatal volume activity (SVA), striatal-specific binding (SSB), and volume-specific uptake ratio (VSUR) were compared between the IPD patients and the normal subjects. In the IPD patients, the correlation between the clinical factor and the functional parameters was assessed. RESULTS The SUVmax, SUVmean, FV, SVA, SSB, and VSUR were significantly lower in the IPD patients than in the normal subjects. In the receiver operating characteristic analysis, those parameters had significant and good-to-excellent accuracy. In the patients with IPD, a moderate negative correlation was revealed between the SUVmax and H&Y stage, the SUVmean and H&Y stage, SVA and H&Y stage, the VSUR and H&Y stage, the FV and bradykinesia, and the SVA and bradykinesia. CONCLUSION The functional volumetric analysis of the striatum based on simple isocontour VOI was a useful method of analyzing the F-18 FP-CIT PET image. Not only can it be easily applied in daily clinical practice, but it can also be used as a clinical parameter to discriminate IPD and to correlate it with the disease severity.
Collapse
|
11
|
Perlaki G, Szekeres S, Orsi G, Papp L, Suha B, Nagy SA, Doczi T, Janszky J, Zambo K, Kovacs N. Validation of an automated morphological MRI-based (123)I-FP-CIT SPECT evaluation method. Parkinsonism Relat Disord 2016; 29:24-9. [PMID: 27290659 DOI: 10.1016/j.parkreldis.2016.06.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/09/2016] [Revised: 05/18/2016] [Accepted: 06/02/2016] [Indexed: 10/21/2022]
Abstract
INTRODUCTION Dopamine transporter imaging with (123)I-FP-CIT single photon emission computed tomography (SPECT) is helpful for the differential diagnosis between Parkinsonian syndrome (PS) and essential tremor (ET). Although visual assessment and time-consuming manual evaluation techniques are readily available, a fully objective and automated dopamine transporter quantification technique is always preferable, at least in research and follow-up investigations. Our aim was to develop a novel automated magnetic resonance imaging (MRI)-based evaluation technique of dopamine transporter SPECT images and to compare its diagnostic accuracy with those of the gold-standard visual grading and manual dopamine transporter binding quantification methods. METHODS (123)I-FP-CIT SPECT and MRI sessions were conducted in 33 patients with PS (15 men; mean age: 60.3 ± 9.7 years) and 15 patients with ET (8 men; mean age: 54.7 ± 16.3 years). Striatal dopamine transporter binding was visually classified by 2 independent experts as normal or abnormal grade I, II and III. Caudal and putaminal specific uptake ratios were calculated by both automated MRI-based and manual evaluation techniques. RESULTS We found almost perfect agreement (κ = 0.829) between the visual scores by the 2 observers. The automated method showed strong correlation with the visual and manual evaluation techniques and its diagnostic accuracy (sensitivity = 97.0%; specificity = 93.3%) was also comparable to these methods. The automatically determined uptake parameters showed negative correlation with the clinical severity of parkinsonism. Based on ordinal regression modelling, the automated MRI-based method could reliably determine the visual grading scores. CONCLUSION The novel MRI-based evaluation of (123)I-FP-CIT SPECT images is useful for the differentiation of PS from ET.
Collapse
Affiliation(s)
- Gabor Perlaki
- MTA-PTE Clinical Neuroscience MR Research Group, H-7623 Pecs, Hungary; Pecs Diagnostic Centre, H-7623 Pecs, Hungary
| | - Sarolta Szekeres
- Department of Nuclear Medicine, University of Pecs, H-7624 Pecs, Hungary
| | - Gergely Orsi
- MTA-PTE Clinical Neuroscience MR Research Group, H-7623 Pecs, Hungary; Pecs Diagnostic Centre, H-7623 Pecs, Hungary
| | - Laszlo Papp
- Mediso Medical Imaging Systems, H-1022 Budapest, Hungary
| | - Balazs Suha
- Department of Nuclear Medicine, University of Pecs, H-7624 Pecs, Hungary
| | - Szilvia Anett Nagy
- Pecs Diagnostic Centre, H-7623 Pecs, Hungary; MTA-PTE Neurobiology of Stress Research Group, H-7624 Pecs, Hungary
| | - Tamas Doczi
- MTA-PTE Clinical Neuroscience MR Research Group, H-7623 Pecs, Hungary; Pecs Diagnostic Centre, H-7623 Pecs, Hungary; Department of Neurosurgery, University of Pecs, H-7623 Pecs, Hungary
| | - Jozsef Janszky
- MTA-PTE Clinical Neuroscience MR Research Group, H-7623 Pecs, Hungary; Department of Neurology, University of Pecs, H-7623 Pecs, Hungary
| | - Katalin Zambo
- Department of Nuclear Medicine, University of Pecs, H-7624 Pecs, Hungary
| | - Norbert Kovacs
- MTA-PTE Clinical Neuroscience MR Research Group, H-7623 Pecs, Hungary; Department of Neurology, University of Pecs, H-7623 Pecs, Hungary.
| |
Collapse
|
12
|
Prashanth R, Roy SD, Mandal PK, Ghosh S. High-Accuracy Classification of Parkinson's Disease Through Shape Analysis and Surface Fitting in 123I-Ioflupane SPECT Imaging. IEEE J Biomed Health Inform 2016; 21:794-802. [PMID: 28113827 DOI: 10.1109/jbhi.2016.2547901] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Early and accurate identification of Parkinsonian syndromes (PS) involving presynaptic degeneration from nondegenerative variants such as scans without evidence of dopaminergic deficit (SWEDD) and tremor disorders is important for effective patient management as the course, therapy, and prognosis differ substantially between the two groups. In this study, we use single photon emission computed tomography (SPECT) images from healthy normal, early PD, and SWEDD subjects, as obtained from the Parkinson's Progression Markers Initiative (PPMI) database, and process them to compute shape- and surface-fitting-based features. We use these features to develop and compare various classification models that can discriminate between scans showing dopaminergic deficit, as in PD, from scans without the deficit, as in healthy normal or SWEDD. Along with it, we also compare these features with striatal binding ratio (SBR)-based features, which are well established and clinically used, by computing a feature-importance score using random forests technique. We observe that the support vector machine (SVM) classifier gives the best performance with an accuracy of 97.29%. These features also show higher importance than the SBR-based features. We infer from the study that shape analysis and surface fitting are useful and promising methods for extracting discriminatory features that can be used to develop diagnostic models that might have the potential to help clinicians in the diagnostic process.
Collapse
|
13
|
Fully Automated Quantification of the Striatal Uptake Ratio of [(99m)Tc]-TRODAT with SPECT Imaging: Evaluation of the Diagnostic Performance in Parkinson's Disease and the Temporal Regression of Striatal Tracer Uptake. BIOMED RESEARCH INTERNATIONAL 2015; 2015:461625. [PMID: 26366413 PMCID: PMC4558437 DOI: 10.1155/2015/461625] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/19/2015] [Revised: 07/09/2015] [Accepted: 07/21/2015] [Indexed: 11/20/2022]
Abstract
Purpose. We aimed at improving the existing methods for the fully automatic quantification of striatal uptake of [99mTc]-TRODAT with SPECT imaging. Procedures. A normal [99mTc]-TRODAT template was first formed based on 28 healthy controls. Images from PD patients (n = 365) and nPD subjects (28 healthy controls and 33 essential tremor patients) were spatially normalized to the normal template. We performed an inverse transform on the predefined striatal and reference volumes of interest (VOIs) and applied the transformed VOIs to the original image data to calculate the striatal-to-reference ratio (SRR). The diagnostic performance of the SRR was determined through receiver operating characteristic (ROC) analysis. Results. The SRR measured with our new and automatic method demonstrated excellent diagnostic performance with 92% sensitivity, 90% specificity, 92% accuracy, and an area under the curve (AUC) of 0.94. For the evaluation of the mean SRR and the clinical duration, a quadratic function fit the data with R2 = 0.84. Conclusions. We developed and validated a fully automatic method for the quantification of the SRR in a large study sample. This method has an excellent diagnostic performance and exhibits a strong correlation between the mean SRR and the clinical duration in PD patients.
Collapse
|
14
|
Brahim A, Ramírez J, Górriz JM, Khedher L, Salas-Gonzalez D. Comparison between Different Intensity Normalization Methods in 123I-Ioflupane Imaging for the Automatic Detection of Parkinsonism. PLoS One 2015; 10:e0130274. [PMID: 26086379 PMCID: PMC4473267 DOI: 10.1371/journal.pone.0130274] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2014] [Accepted: 05/19/2015] [Indexed: 11/18/2022] Open
Abstract
Intensity normalization is an important pre-processing step in the study and analysis of DaTSCAN SPECT imaging. As most automatic supervised image segmentation and classification methods base their assumptions regarding the intensity distributions on a standardized intensity range, intensity normalization takes on a very significant role. In this work, a comparison between different novel intensity normalization methods is presented. These proposed methodologies are based on Gaussian Mixture Model (GMM) image filtering and mean-squared error (MSE) optimization. The GMM-based image filtering method is achieved according to a probability threshold that removes the clusters whose likelihood are negligible in the non-specific regions. The MSE optimization method consists of a linear transformation that is obtained by minimizing the MSE in the non-specific region between the intensity normalized image and the template. The proposed intensity normalization methods are compared to: i) a standard approach based on the specific-to-non-specific binding ratio that is widely used, and ii) a linear approach based on the α-stable distribution. This comparison is performed on a DaTSCAN image database comprising analysis and classification stages for the development of a computer aided diagnosis (CAD) system for Parkinsonian syndrome (PS) detection. In addition, these proposed methods correct spatially varying artifacts that modulate the intensity of the images. Finally, using the leave-one-out cross-validation technique over these two approaches, the system achieves results up to a 92.91% of accuracy, 94.64% of sensitivity and 92.65 % of specificity, outperforming previous approaches based on a standard and a linear approach, which are used as a reference. The use of advanced intensity normalization techniques, such as the GMM-based image filtering and the MSE optimization improves the diagnosis of PS.
Collapse
Affiliation(s)
- A. Brahim
- Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain
| | - J. Ramírez
- Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain
| | - J. M. Górriz
- Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain
| | - L. Khedher
- Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain
| | - D. Salas-Gonzalez
- Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain
| |
Collapse
|
15
|
The feasibility of using CT-guided ROI for semiquantifying striatal dopamine transporter availability in a hybrid SPECT/CT system. ScientificWorldJournal 2014; 2014:879497. [PMID: 25531005 PMCID: PMC4233671 DOI: 10.1155/2014/879497] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2014] [Revised: 09/22/2014] [Accepted: 09/23/2014] [Indexed: 11/18/2022] Open
Abstract
A hybrid SPECT/CT system provides accurate coregistration of functional and morphological images. CT-guided region of interest (ROI) for semiquantifying striatal dopamine transporter (DAT) availability may be a feasible method. We therefore assessed the intra- and interobserver reproducibility of manual SPECT and CT-guided ROI methods and compared their semiquantitative data with data from MRI-guided ROIs. We enrolled twenty-eight patients who underwent Tc-99m TRODAT-1 brain SPECT/CT and brain MRI. ROIs of the striatal, caudate, putamen, and occipital cortex were manually delineated on the SPECT, CT, and MRI. ROIs from CT and MRI were transferred to the coregistered SPECT for semiquantification. The striatal, caudate, and putamen nondisplaceable binding potential (BPND) were calculated. Using CT-guided ROIs had higher intra- and interobserver concordance correlation coefficients, closer Bland-Altman biases to zero, and narrower limits of agreement than using manual SPECT ROIs. The correlation coefficients of striatal, caudate, and putamen BPND were good between manual SPECT and MRI-guided ROI methods and even better between CT-guided and MRI-guided ROI methods. Conclusively, CT-guided ROI delineation for semiquantifying striatal DAT availability in a hybrid SPECT/CT system is highly reproducible, and the semiquantitative data correlate well with data from MRI-guided ROIs.
Collapse
|
16
|
Martinez-Murcia FJ, Górriz JM, Ramírez J, Moreno-Caballero M, Gómez-Río M. Parametrization of textural patterns in 123I-ioflupane imaging for the automatic detection of Parkinsonism. Med Phys 2014; 41:012502. [PMID: 24387526 DOI: 10.1118/1.4845115] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE A novel approach to a computer aided diagnosis system for the Parkinson's disease is proposed. This tool is intended as a supporting tool for physicians, based on fully automated methods that lead to the classification of (123)I-ioflupane SPECT images. METHODS (123)I-ioflupane images from three different databases are used to train the system. The images are intensity and spatially normalized, then subimages are extracted and a 3D gray-level co-occurrence matrix is computed over these subimages, allowing the characterization of the texture using Haralick texture features. Finally, different discrimination estimation methods are used to select a feature vector that can be used to train and test the classifier. RESULTS Using the leave-one-out cross-validation technique over these three databases, the system achieves results up to a 97.4% of accuracy, and 99.1% of sensitivity, with positive likelihood ratios over 27. CONCLUSIONS The system presents a robust feature extraction method that helps physicians in the diagnosis task by providing objective, operator-independent textural information about (123)I-ioflupane images, commonly used in the diagnosis of the Parkinson's disease. Textural features computation has been optimized by using a subimage selection algorithm, and the discrimination estimation methods used here makes the system feature-independent, allowing us to extend it to other databases and diseases.
Collapse
Affiliation(s)
- F J Martinez-Murcia
- Signal Processing and Biomedical Applications Research Group, Department of Signal Theory, Networking and Communications, University of Granada, Granada 18071, Spain
| | - J M Górriz
- Signal Processing and Biomedical Applications Research Group, Department of Signal Theory, Networking and Communications, University of Granada, Granada 18071, Spain
| | - J Ramírez
- Signal Processing and Biomedical Applications Research Group, Department of Signal Theory, Networking and Communications, University of Granada, Granada 18071, Spain
| | - M Moreno-Caballero
- Department of Nuclear Medicine, Virgen de las Nieves Hospital, Granada 18071, Spain
| | - M Gómez-Río
- Department of Nuclear Medicine, Virgen de las Nieves Hospital, Granada 18071, Spain
| |
Collapse
|
17
|
Martínez-Murcia F, Górriz J, Ramírez J, Illán I, Ortiz A. Automatic detection of Parkinsonism using significance measures and component analysis in DaTSCAN imaging. Neurocomputing 2014. [DOI: 10.1016/j.neucom.2013.01.054] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
18
|
García-Gómez F, García-Solís D, Luis-Simón F, Marín-Oyaga V, Carrillo F, Mir P, Vázquez-Albertino R. Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane. Rev Esp Med Nucl Imagen Mol 2013. [DOI: 10.1016/j.remnie.2013.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
19
|
Roussakis AA, Piccini P, Politis M. Clinical utility of DaTscan™ (123I-Ioflupane Injection) in the diagnosis of Parkinsonian Syndromes. Degener Neurol Neuromuscul Dis 2013; 3:33-39. [PMID: 30890892 DOI: 10.2147/dnnd.s19807] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The diagnosis of movement disorders including Parkinsonian syndromes and essential tremor is mainly clinical. The most common diagnostic errors for Parkinson's disease include misdiagnoses such as Parkinson plus syndromes and cases of essential tremor. In this article, we discuss the clinical utility of DaTscan™ (123I-Ioflupane injection) and its diagnostic value in Parkinson's disease and the other Parkinsonian syndromes. Single photon emission computed tomography with 123I-Ioflupane can be useful to assist in the diagnosis of uncertain cases of Parkinsonism. An accurate diagnosis can aid clinicians in making correct decisions that are related to the overall management and treatment of Parkinson's disease, avoiding common therapeutic errors.
Collapse
Affiliation(s)
| | - Paola Piccini
- Centre for Neuroinflammation and Neurodegeneration, Imperial College London, London, United Kingdom,
| | - Marios Politis
- Centre for Neuroinflammation and Neurodegeneration, Imperial College London, London, United Kingdom,
| |
Collapse
|
20
|
Passamonti L, Salsone M, Toschi N, Cerasa A, Giannelli M, Chiriaco C, Cascini GL, Fera F, Quattrone A. Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease. Brain Behav 2013; 3:249-62. [PMID: 23785657 PMCID: PMC3683285 DOI: 10.1002/brb3.115] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/24/2012] [Revised: 11/15/2012] [Accepted: 11/30/2012] [Indexed: 11/21/2022] Open
Abstract
Dopaminergic therapy in Parkinson's disease (PD) can improve some cognitive functions while worsening others. These opposite effects might reflect different levels of residual dopamine in distinct parts of the striatum, although the underlying mechanisms remain poorly understood. We used functional magnetic resonance imaging (fMRI) to address how apomorphine, a potent dopamine agonist, influences brain activity associated with working memory in PD patients with variable levels of nigrostriatal degeneration, as assessed via dopamine-transporter (DAT) scan. Twelve PD patients underwent two fMRI sessions (Off-, On-apomorphine) and one DAT-scan session. Twelve sex-, age-, and education-matched healthy controls underwent one fMRI session. The core fMRI analyses explored: (1) the main effect of group; (2) the main effect of treatment; and (3) linear and nonlinear interactions between treatment and DAT levels. Relative to controls, PD-Off patients showed greater activations within posterior attentional regions (e.g., precuneus). PD-On versus PD-Off patients displayed reduced left superior frontal gyrus activation and enhanced striatal activation during working-memory task. The relation between DAT levels and striatal responses to apomorphine followed an inverted-U-shaped model (i.e., the apomorphine effect on striatal activity in PD patients with intermediate DAT levels was opposite to that observed in PD patients with higher and lower DAT levels). Previous research in PD demonstrated that the nigrostriatal degeneration (tracked via DAT scan) is associated with inverted-U-shaped rearrangements of postsynaptic D2-receptors sensitivity. Hence, it can be hypothesized that individual differences in DAT levels drove striatal responses to apomorphine via D2-receptor-mediated mechanisms.
Collapse
Affiliation(s)
- Luca Passamonti
- Istituto di Scienze Neurologiche (ISN), Consiglio Nazionale delle Ricerche 88100, Catanzaro, Italia ; Dipartimento di Scienze Mediche e Chirurgiche, Università degli Studi "Magna Graecia" 88100, Catanzaro, Italia
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
García-Gómez FJ, García-Solís D, Luis-Simón FJ, Marín-Oyaga VA, Carrillo F, Mir P, Vázquez-Albertino RJ. [Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane]. Rev Esp Med Nucl Imagen Mol 2013; 32:350-6. [PMID: 23570700 DOI: 10.1016/j.remn.2013.02.009] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2012] [Revised: 02/05/2013] [Accepted: 02/23/2013] [Indexed: 11/28/2022]
Abstract
PURPOSE Statistical parametric mapping (SPM) is a widely used produced for normalization of functional images. This study has aimed to develop a normalization template of (123)I-Ioflupane SPECT-imaging DaTSCAN(®), GE Healthcare), not available in SPM5, and to validate it compared to other quantification methods. MATERIAL AND METHODS In order to write the template we retrospectively selected 26 subjects who had no evidence of nigrostriatal degeneration and whose age distribution was similar to that of the patients in the usual practice of our Department: 2 subjects (7.6%) were < 35 years, 9 between 35-65 years (34.6%) and 15 > 65 years (57.7%). All the studies were normalized with the T1-template available in SPM5 and an average image of the value was obtained for each voxel. For validation we analyzed 60 patients: 30 with idiopathic Parkinson's disease patients (iPD) with right involvement (66.83±12.20 years) and 30 with essential tremor patients (ET) (67.27±8.33 years). Specific uptake rates (SUR) of different striatal regions were compared after image normalization with our template and the application of a semiautomated VOIs-map created with Analyze v9.0 ((©)BIR, Mayo Clinic), against two quantification methods: a) manual adjustment of a ROIs-map drawn in Analyze, and b) semi-automated method (HERMES-BRASS) with normalization and implementation of VOIs-map. RESULTS No statistically significant differences in the iPD/ET discriminatory capacity between the three methods analyzed were observed (p<0,001). The correlation of SUR after normalization with our «template» was higher than that obtained by method b) (R>0,871, p<0,001). This difference was greater in patients with PD. CONCLUSIONS Our study demonstrates the efficacy of our SPM «template» for (123)I-Ioflupane SPECT-imaging, obtained from normalization with «T1-template».
Collapse
Affiliation(s)
- F J García-Gómez
- Servicio de Medicina Nuclear, UDIM, Hospital Universitario Virgen del Rocío, Sevilla, España.
| | | | | | | | | | | | | |
Collapse
|
22
|
Söderlund TA, Dickson JC, Prvulovich E, Ben-Haim S, Kemp P, Booij J, Nobili F, Thomsen G, Sabri O, Koulibaly PM, Akdemir OU, Pagani M, van Laere K, Asenbaum-Nan S, George J, Sera T, Tatsch K, Bomanji J. Value of Semiquantitative Analysis for Clinical Reporting of 123I-2-β-Carbomethoxy-3β-(4-Iodophenyl)-N-(3-Fluoropropyl)Nortropane SPECT Studies. J Nucl Med 2013; 54:714-22. [DOI: 10.2967/jnumed.112.110106] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
|
23
|
Illan IA, Gorrz JM, Ramirez J, Segovia F, Jimenez-Hoyuela JM, Ortega Lozano SJ. Automatic assistance to Parkinson's disease diagnosis in DaTSCAN SPECT imaging. Med Phys 2012; 39:5971-80. [PMID: 23039635 DOI: 10.1118/1.4742055] [Citation(s) in RCA: 83] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE In this work, an approach to computer aided diagnosis (CAD) system is proposed as a decision-making aid in Parkinsonian syndrome (PS) detection. This tool, intended for physicians, entails fully automatic preprocessing, normalization, and classification procedures for brain single-photon emission computed tomography images. METHODS Ioflupane[(123)I]FP-CIT images are used to provide in vivo information of the dopamine transporter density. These images are preprocessed using an automated template-based registration followed by two proposed approaches for intensity normalization. A support vector machine (SVM) is used and compared to other statistical classifiers in order to achieve an effective diagnosis using whole brain images in combination with voxel selection masks. RESULTS The CAD system is evaluated using a database consisting of 208 DaTSCAN images (100 controls, 108 PS). SVM-based classification is the most efficient choice when masked brain images are used. The generalization performance is estimated to be 89.02 (90.41-87.62)% sensitivity and 93.21 (92.24-94.18)% specificity. The area under the curve can take values of 0.9681 (0.9641-0.9722) when the image intensity is normalized to a maximum value, as derived from the receiver operating characteristics curves. CONCLUSIONS The present analysis allows to evaluate the impact of the design elements for the development of a CAD-system when all the information encoded in the scans is considered. In this way, the proposed CAD-system shows interesting properties for clinical use, such as being fast, automatic, and robust.
Collapse
Affiliation(s)
- I A Illan
- Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain.
| | | | | | | | | | | |
Collapse
|
24
|
Tinazzi M, Cipriani A, Matinella A, Cannas A, Solla P, Nicoletti A, Zappia M, Morgante L, Morgante F, Pacchetti C, Sciarretta M, Dallocchio C, Rossi S, Malentacchi M, Ceravolo R, Frosini D, Sestini S, Bovi T, Barbui C. [¹²³I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. Schizophr Res 2012; 139:40-5. [PMID: 22727453 DOI: 10.1016/j.schres.2012.06.003] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/28/2011] [Revised: 05/08/2012] [Accepted: 06/02/2012] [Indexed: 10/28/2022]
Abstract
Drug-induced parkinsonism (DIP) in patients treated with antipsychotic drugs is considered a form of post-synaptic parkinsonism, caused by D2-receptor blockade. Recent studies, however, carried out on small and heterogeneous patient samples, have shown that DIP may be associated with [(123)I]FP-CIT single photon emission computed tomography (SPECT) abnormalities, which are markers of dopamine nigrostriatal terminal defect. In the present study, outpatients fulfilling the DSM-IV criteria for schizophrenia and treated with antipsychotics for at least 6 months, were enrolled in order to estimate the prevalence of DIP and, among patients with DIP, the prevalence of [(123)I]FP-CIT SPECT abnormalities. Socio-demographic and clinical variables associated with the presence of DIP and SPECT abnormalities were also assessed. DIP was diagnosed in 149 out of 448 patients with schizophrenia (33%). Age, use of long-acting antipsychotics and a positive family history of parkinsonism were the only demographic variables significantly associated with the development of DIP. Neuroimaging abnormalities were found in 41 of 97 patients who agreed to undergo [(123)I]FP-CIT SPECT (42%). Only age differentiated this group of patients from those with normal imaging. These preliminary findings suggest that D2-receptor blockade may coexist with a dopamine nigrostriatal terminal defect, as assessed by [(123)I]FP-CIT SPECT abnormalities, in a relevant proportion of DIP patients. Longitudinal studies should be designed with the aim of improving our understanding of the mechanisms of pre-synaptic abnormalities in DIP patients and identifying specific treatment strategies.
Collapse
Affiliation(s)
- Michele Tinazzi
- Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I]β-CIT SPECT. Eur J Nucl Med Mol Imaging 2012; 39:1012-20. [DOI: 10.1007/s00259-012-2100-5] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2011] [Accepted: 02/22/2012] [Indexed: 10/28/2022]
|
26
|
Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 2011; 134:3146-66. [PMID: 21810889 DOI: 10.1093/brain/awr177] [Citation(s) in RCA: 149] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Diagnosis of neurological and psychiatric conditions associated with disturbances of dopaminergic functioning can be challenging, especially in the early stages, and may be assisted with biomarkers such as dopamine system imaging. Distinguishing between Alzheimer's disease and dementia with Lewy bodies is a major diagnostic challenge. Clinical diagnosis of Parkinson's disease is straightforward with classic presentation, but accurate distinction among Parkinsonian variants may be difficult; non-Parkinson's disease conditions are commonly misdiagnosed as Parkinson's disease, and ~20% of patients with Parkinson's disease are not clinically diagnosed despite coming to medical attention. Early and accurate diagnosis is desirable to improve management. Imaging of the dopamine transporter using single-photon emission computed tomography may be of particular utility in this regard. Abnormal imaging indicates underlying nigrostriatal neurodegeneration, supportive of a diagnosis of Parkinson's disease, atypical parkinsonism or dementia with Lewy bodies, and identifies patient groups in whom dopaminergic therapy may be beneficial. Normal imaging supports diagnosis of a condition not involving nigrostriatal neurodegeneration such as Alzheimer's disease, essential tremor or drug-induced parkinsonism and hence a different therapeutic approach. In patients in whom there was diagnostic uncertainty between degenerative parkinsonism and non-degenerative tremor disorders, baseline imaging with the dopamine transporter ligand [(123)I]ioflupane (DaTscan™) has shown 78% sensitivity and 97% specificity with reference to clinical diagnosis at 3 years, versus 93% and 46%, respectively, for baseline clinical diagnosis. In a Phase III trial of [(123)I]ioflupane in patients with initial clinical diagnosis of probable or possible dementia with Lewy bodies or non-Lewy body dementia, mean specificity for excluding non-Lewy body dementia (predominantly Alzheimer's disease) was 90.4%. Using clinical diagnosis as a reference against which to assess sensitivity and specificity of dopamine transporter imaging is a limitation, but definitive diagnosis via pathological confirmation is generally not feasible. In a series of patients with post-mortem brain examination, imaging using [(123)I]ioflupane has demonstrated higher sensitivity (88%) and specificity (100%) for differentiating dementia with Lewy bodies from non-Lewy body dementia than clinical diagnosis (75% and 42%, respectively). Dopaminergic system imaging may be particularly valuable in patients with clinically inconclusive parkinsonism or a clinical diagnosis of possible dementia with Lewy bodies; it is not helpful in differentiating between Parkinson's disease and atypical parkinsonism, although postsynaptic dopaminergic imaging may be of utility. Other potential uses of dopamine transporter imaging include identification of patients with premotor Parkinson's disease, monitoring disease progression in testing novel therapeutics, and as an inclusion criterion for entry into clinical trials.
Collapse
|
27
|
Südmeyer M, Antke C, Zizek T, Beu M, Nikolaus S, Wojtecki L, Schnitzler A, Müller HW. Diagnostic Accuracy of Combined FP-CIT, IBZM, and MIBG Scintigraphy in the Differential Diagnosis of Degenerative Parkinsonism: A Multidimensional Statistical Approach. J Nucl Med 2011; 52:733-40. [DOI: 10.2967/jnumed.110.086959] [Citation(s) in RCA: 69] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
28
|
Ortega Lozano SJ, Martinez Del Valle Torres MD, Ramos Moreno E, Sanz Viedma S, Amrani Raissouni T, Jiménez-Hoyuela JM. [Quantitative evaluation of SPECT with FP-CIT. Importance of the reference area]. ACTA ACUST UNITED AC 2010; 29:246-50. [PMID: 20655624 DOI: 10.1016/j.remn.2010.03.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2010] [Revised: 03/09/2010] [Accepted: 03/30/2010] [Indexed: 11/26/2022]
Abstract
OBJECTIVE The aim of this study is to compare several uptake indexes between specific and non-specific activity to determine the existence of degenerative Parkinsonism according to different reference areas. MATERIAL AND METHODS A total of 46 patients (23 men and 23 women), randomly selected from individuals referred to our center with a movement disorder, were included in the study. Mean age was 70.2 ± 10.2 years (41-87). The uptake indexes were obtained through the areas of interest (ROIs) located in the striate (specific uptake) and other reference ROIs located in areas with different concentrations of serotonin receptors: low-cerebellum, medium-occipital cortex and high-midbrain. RESULTS A high linear correlation was found between indexes having low and medium concentration of serotonin receptors. The ROC curve analysis shows an area under the curve of 0.874, 0.886 and 0.739 and regression coefficients of 5.41, 6.62 and 3.41, respectively for the striatum/cerebellum (E/C), striatum/occipital (E/O) and striatum midbrain (E/M) indexes. Optimal cutoff for E/O (1.35), index with the best behavior, provides a sensitivity of 0.84 and specificity of 0.89. CONCLUSION The reference area selected may alter the predictive power of the different indexes to determine the existence of a degenerative Parkinsonism.
Collapse
Affiliation(s)
- S J Ortega Lozano
- Servicio de Medicina Nuclear, Hospital Universitario «Virgen de la Victoria», Málaga, España.
| | | | | | | | | | | |
Collapse
|
29
|
|